Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Amgen Adds S. Omar Ishrak, Former Chairman & CEO of Medtronic, To Board Of Directors

By John F. Heerdink, Jr.

Reportedly, Amgen (AMGN) has appointed S. Omar Ishrak to its Board of Directors, effective July 30, 2021. Dr. Ishrak will also serve as a member of the Board’s Corporate Responsibility and Compliance Committee and its Compensation and Management Development Committee. The Board now consists of 12 directors after Dr. Ishrak’s appointment, 11 of whom are independent.

“Omar is an accomplished business leader with deep experience in a fast-paced, technology-driven sector of the healthcare industry. I’m confident he will add great value to Amgen as we look to harness advances in science and technology and accelerate our pace of innovation to reach more patients.” stated Robert A. Bradway, chairman and chief executive officer of Amgen.

Dr. Ishrak served as chairman and chief executive officer of Medtronic plc, a global medical technology company, from 2011 to 2020. Prior to joining Medtronic, Dr. Ishrak held numerous leadership positions at GE Healthcare, serving as president and chief executive officer of GE Healthcare Systems, GE Healthcare Clinical Systems, and GE Healthcare Ultrasound in his tenure for more than 15 years with the company. Dr. Ishrak was born in Bangladesh and received his undergraduate degree and doctorate from the University of London, King’s College.

If you liked this story please consider, visiting the Atossa Therapeutics (ATOS) dedicated page at Vista Partners to learn about the Seattle-based biotech firm’s work towards finding therapeutic treatments for Breast Cancer and the Coronavirus. 

Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.

Stay Informed! Stay Competitive! Please join us at Vista Partners and receive our FREE email updates throughout the week and view our exclusive content and research.

(Read Original Story: Amgen Appoints S. Omar Ishrak To Board Of Directors in PR Newswire)


Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us